Apertura Gene Therapy expands access to capsids
Apertura Gene Therapy and partners plan to simplify production and access to engineered AAV capsids for biotech startups.
- Field
- gene therapy
- What they did
- Apertura Gene Therapy shared its experience developing and manufacturing viral capsids for gene therapy to demonstrate how the process works.
- Why it matters
- This helps other organizations and researchers gain access to these technologies and start using them in their own projects.
#gene therapy#aav capsids#manufacturing#collaboration



